Evaluation of Suspected Liver Pathology in Patients With Contraindications for Contrast Enhanced CT and/or MRI
Status:
Withdrawn
Trial end date:
2018-03-01
Target enrollment:
Participant gender:
Summary
Patients with renal failure or other reason for contraindication for contrast enhanced
computed tomography (CECT) or contrast enhanced magnetic resonance imaging (CEMRI) with
suspected liver pathology will be evaluated with Sonazoid enhanced Ultrasound
Phase:
Phase 3
Details
Lead Sponsor:
Northeastern Ohio Radiology Research and Education Fund